Aug 26, 2025 • GlobeNewswire
NEUTRAL
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
- Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease ( IBD ) and potentially another autoimmune disease ...
Aug 26, 2025 • Benzinga
NEUTRAL
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors - Disc Medicine ( NASDAQ:IRON ) , Shattuck Labs ( NASDAQ:STTK )
- Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease ( IBD ) and potentially another autoimmune disease -
Aug 14, 2025 • Benzinga
BULLISH
Paul Oakenfold to Join Space2Sea's Galápagos Voyage of Discovery
GALÁPAGOS ISLANDS, Ecuador, Aug. 13, 2025 /PRNewswire/ -- November 1-8, 2025 - World-renowned DJ and music producer will bring his signature sound to an intimate, fully private expedition blending exploration, science, and culture alongside Neil deGrasse Tyson, Kathryn Sullivan, Beth Shapiro, ...
Aug 06, 2025 • GlobeNewswire
SOMEWHAT-BULLISH
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy ( RMAT ) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
Mechelen, Belgium. August 6, 2025, 7:30 CET. regulated information - inside information - Galapagos NV ( Euronext & NASDAQ: GLPG ) today announced that the United States Food and Drug Administration ( FDA ) has granted RMAT designation to GLPG5101, a second generation anti-CD19/4-1BB CAR-T ...
Aug 06, 2025 • Benzinga
SOMEWHAT-BULLISH
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy ( RMAT ) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma - Galapagos ( NASDAQ:GLPG )
The RMAT designation was established under the U.S. 21st Century Cures Act to accelerate development and review of promising cell and gene therapies for serious or life-threatening conditions.
Aug 05, 2025 • Benzinga
BULLISH
SET SAIL ON A VACATION THAT NOTHING COMES CLOSE TO, AS CELEBRITY CRUISES REVEALS THE FIRST OF ITS 2027-2028 ITINERARIES - Royal Caribbean Gr ( NYSE:RCL )
Explore breathtaking landscapes and iconic cities with more than 175 sailings in Europe, Alaska, Hawaii, Australia, Japan, Canada and New England.